The use of intravenous immunoglobulins in Belgium

International Archives of Allergy and Immunology

Volumn 154, Issue 2, 2011, Pages 173-176

  Simoens, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Belgium; Immunoglobulins, intravenous; Off label use; Reimbursement

Indexed keywords

IMMUNOGLOBULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BELGIUM; DATA BASE; DRUG COST; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYASTHENIA GRAVIS; OFF LABEL DRUG USE; PRIORITY JOURNAL; REIMBURSEMENT;

BELGIUM; COST-BENEFIT ANALYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; OFF-LABEL USE;

EID: 77956090042     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320232     Document Type: Article

References (9)

1. Kallenberg CGM, Laseur M: Cost considerations in choosing an intravenous immunoglobulin preparation. Eur J Hosp Pharm Pract 2007; 13: 6-7
2. Chen C, Danekas LH, Ratko TA, Vlasses PH, Matuszewski KA: A multicenter drug use surveillance of intravenous immunoglobulin utilization in US academic health centers. Ann Pharmacother 2000; 34: 295-299
3. Kumar A, Teuber SS, Gershwin ME: Intravenous immunoglobulin: striving for appropriate use. Int Arch Allergy Immunol 2006; 140: 185-198
4. Darabi K, Abdel-Wahab O, Dzik WH: Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 2006; 46: 741-753
5. Alangari AA, Abutaleb MH, Albarraq AA, Al-Dhowailie AA: Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia. Saudi Med J 2008; 29: 975-979
6. Sacher RA: Intravenous immunoglobulin consensus statement. J Allergy Clin Immunol 2001; 108:S139-S146
7. Bjorkander J, Nikoskelainen J, Leibl H, Lanbeck P, Wallvik J, Lumio JT, Braconier JH, Pavlova BG, Birthistle K, Engl W, Walter S, Ehrlich HJ: Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia. Vox Sang 2006; 90: 286-293
8. Simoens S: Pharmaco-economics of immunoglobulins in primary immunodeficiency. Expert Rev Pharmacoecon Outcomes Res 2009; 9: 375-386
9. Constantine MM, Thomas W, Whitman L, Kahwash E, Dolan S, Smith S, Caudle CJ, Burton E, Anderson DR: Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group. Transfusion 2007; 47: 2072-2080